Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT06801834. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Global, Multicenter, Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Standard of Care (SOC) in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this clinical study is to learn more about the study drug sacituzumab govitecan (SG; Trodelvy®; GS-0132; IMMU 132), versus standard of care (SOC) in participants with previously treated extensive stage small cell lung cancer (ES-SCLC). The primary objectives of this study are to compare the effect of SG to SOC on overall survival (OS).
Study identification
- NCT ID
- NCT06801834
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 695 participants
Conditions and interventions
Interventions
- Sacituzumab Govitecan (SG) Drug
- Topotecan Drug
- Amrubicin (Japan only) Drug
- Lurbinectedin (regions/countries where approved and available) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 3, 2025
- Primary completion
- Sep 30, 2029
- Completion
- Sep 30, 2029
- Last update posted
- Aug 11, 2026
2025 – 2029
United States locations
- U.S. sites
- 23
- U.S. states
- 14
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alaska Oncology and Hematology | Anchorage | Alaska | 99508 | Recruiting |
| Genesis Cancer and Blood Institute | Hot Springs | Arkansas | 71913 | Recruiting |
| Los Angeles Cancer Network | Anaheim | California | 92801 | Recruiting |
| Boca Raton Regional | Miami | Florida | 33143 | Recruiting |
| Hope and Healing Cancer Services | Hinsdale | Illinois | 60521 | Recruiting |
| Southern Illinois University School of Medicine | Springfield | Illinois | 62702 | Recruiting |
| Springfield Clinic | Springfield | Illinois | 62702 | Recruiting |
| Parkview Research Center | Fort Wayne | Indiana | 46845 | Recruiting |
| IU Health Ball Memorial Hospital and Physicians - Cancer Center - Muncie | Muncie | Indiana | 47303 | Recruiting |
| Northwest Cancer Centers | Dyer | Kentucky | 46311 | Recruiting |
| St. Claire Regional Medical Ce | Morehead | Kentucky | 40351 | Recruiting |
| Owensboro Health Mitchell Memorial Cancer Center | Owensboro | Kentucky | 42303 | Not yet recruiting |
| MaineHealth Cancer Care | Scarborough | Maine | 04074 | Not yet recruiting |
| OptumCare Cancer Care | Las Vegas | Nevada | 89102 | Not yet recruiting |
| New Mexico Oncology Hematology Consultants, Ltd | Albuquerque | New Mexico | 87109 | Recruiting |
| University Hospitals Seidman Cancer Center | Sandusky | Ohio | 44870 | Recruiting |
| Taylor Cancer Research Foundation | Toledo | Ohio | 43617 | Recruiting |
| Spoknwrd Clinical Trials Inc. | Easton | Pennsylvania | 18045 | Recruiting |
| Hendrick Health System | Abilene | Texas | 79601 | Recruiting |
| MD Anderson Cancer Center | Houston | Texas | 77030 | Recruiting |
| Texas Oncology - San Antonio | New Braunfels | Texas | 78130 | Recruiting |
| The University of Texas Health Science Center at Tyler | Tyler | Texas | 75708 | Recruiting |
| Gundersen Health System | West Salem | Wisconsin | 54601 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 197 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06801834, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 11, 2026 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06801834 live on ClinicalTrials.gov.